Israel is rapidly becoming the promised land of medical cannabis research — and, potentially, the source of medical-grade marijuana for researchers the world over. In yet another first from the country where researchers first isolated THC and discovered the body’s endocannabinoid system, an Israeli researcher is laying plans to conduct the world’s first study into whether cannabis aids people with autism. Dr. Adi Eran’s planned investigation into whether medical cannabis will aid 120 “low to medium functioning” autistic individuals will have the blessing of Israel’s Health Ministry, and will be the “first of its type,” according to Haaretz.
One of autism’s best-known symptoms is an inability to understand “normal” social cues.
Studies have shown that increased activity at the CB1 endocannabinoid receptor has improved social function, suggesting that a potential treatment in autism may lie in